Oxygenta Pharmaceutical share news and announcements
BSE: 524636Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹47.00.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹170 Cr2,423rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Net worth zero or below
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 27 Jul 2026
- −15.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,726
Oxygenta Pharmaceutical share news and announcements
489 announcements, routine notices left out, newest first. Page 3 of 10.
Oct 2024
Sep 2024
27 Sep · Announcement Under Regulation 30 Of The SEBI(LODR) Regulations
5 Sep · Board meeting
Aug 2024
8 Aug · Board meeting
Meeting on 14 Aug 2024: quarterly results5 Aug · Updates on Open Offer - Recommendations of Committee of Independent Directors ("IDC")
May 2024
30 May · Board meeting
23 May · Board meeting
Meeting on 30 May 2024: audited results21 May · Announcement under Regulation 30 (LODR)-Allotment
Apr 2024
26 Apr · Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2024.
25 Apr · Compliance Certificate Under Reg.40 (9) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended 31St March, 2024.
25 Apr · Draft Letter of Offer
18 Apr · Detailed Public Statement
3 Apr · Board meeting
Meeting on 8 Apr 2024: preferential issue of shares
Mar 2024
Feb 2024
6 Feb · Board meeting
Meeting on 14 Feb 2024: quarterly results
Jan 2024
25 Jan · Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
Nov 2023
6 Nov · Board meeting
Meeting on 14 Nov 2023: quarterly results